| 000 | 01651 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514063626.0 | ||
| 264 | 0 | _c20030425 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0003-3197 | ||
| 024 | 7 |
_a10.1177/000331970305400212 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTallarico, Demetrio | |
| 245 | 0 | 0 |
_aMyocardial cytoprotection by trimetazidine against anthracycline-induced cardiotoxicity in anticancer chemotherapy. _h[electronic resource] |
| 260 |
_bAngiology _c |
||
| 300 |
_a219-27 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCardiovascular Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDiastole _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRazoxane _xtherapeutic use |
| 650 | 0 | 4 |
_aTrimetazidine _xpharmacology |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aRizzo, Vito | |
| 700 | 1 | _aDi Maio, Fernando | |
| 700 | 1 | _aPetretto, Federica | |
| 700 | 1 | _aBianco, Gianluca | |
| 700 | 1 | _aPlacanica, Giuseppe | |
| 700 | 1 | _aMarziali, Marta | |
| 700 | 1 | _aParavati, Vincenzo | |
| 700 | 1 | _aGueli, Nicolò | |
| 700 | 1 | _aMeloni, Fortunato | |
| 700 | 1 | _aCampbell, Stefano Villatico | |
| 773 | 0 |
_tAngiology _gvol. 54 _gno. 2 _gp. 219-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/000331970305400212 _zAvailable from publisher's website |
| 999 |
_c12470862 _d12470862 |
||